Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.120 | 14 | 68232877 | intron variant | C/T | snv | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.830 | 1.000 | 4 | 2012 | 2019 | |||||||
|
1.000 | 0.040 | 14 | 68318360 | intron variant | G/A | snv | 0.54 |
|
Eye Diseases | 0.830 | 1.000 | 4 | 2013 | 2019 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.820 | 1.000 | 6 | 2012 | 2017 | |||||||
|
0.851 | 0.200 | 14 | 68286876 | intron variant | C/T | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.800 | 1.000 | 3 | 2011 | 2015 | |||||||
|
1.000 | 0.080 | 14 | 68214759 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.925 | 0.160 | 14 | 68293424 | intron variant | C/G;T | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2014 | 2019 | ||||||||
|
14 | 68054189 | intron variant | G/A | snv | 0.18 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
0.776 | 0.200 | 14 | 68567965 | intron variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.770 | 0.909 | 11 | 2009 | 2017 | |||||||
|
0.776 | 0.200 | 14 | 68567965 | intron variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.770 | 0.889 | 9 | 2009 | 2016 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 3 | 2013 | 2016 | |||||||
|
0.851 | 0.200 | 14 | 68286876 | intron variant | C/T | snv | 0.57 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.720 | 1.000 | 3 | 2013 | 2017 | |||||||
|
14 | 68682711 | intron variant | A/C;T | snv |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||||||
|
0.925 | 0.080 | 14 | 68660027 | intron variant | T/C | snv | 0.53 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2013 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 68276590 | intron variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
14 | 68713254 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
14 | 68713254 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
14 | 68713254 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
14 | 68713254 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
14 | 68713254 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.080 | 14 | 68205006 | intron variant | C/A | snv | 0.17 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
14 | 68026441 | intron variant | G/A | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
14 | 68026441 | intron variant | G/A | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
14 | 68047559 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
14 | 68439257 | intron variant | C/T | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 14 | 68513118 | intron variant | T/C | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 |